Andy Sassine, Director at Gemphire Therapeutics Inc. (GEMP), bought 42,238 shares at $9.47 ($400K) on 2017-03-10, disclosed to the SEC on 2017-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.47 | 21,119 | $200K | 50.0% |
| 2 | $9.47 | 21,119 | $200K | 50.0% |
| Total | $9.47 avg | 42,238 | $400K | 100% |
| Filing → |
| ICAD | SELL | 2022-02-09 | $108K | — | Filing → |
| ICAD | SELL | 2022-01-11 | $123K | — | Filing → |
| ICAD | SELL | 2021-12-08 | $140K | — | Filing → |